Milestone Scientific (MLSS) Cash & Equivalents (2010 - 2026)

Milestone Scientific has reported Cash & Equivalents for 17 years, with the latest figure at $250000.0 in Q1 2026.

• Quarterly Cash & Equivalents fell 88.87% year-over-year to $250000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $250000.0 (down 88.87% YoY) and the FY2025 annual result came in at $1.1 million, down 65.85% from the prior year.
• Cash & Equivalents slipped to $250000.0 in Q1 2026 per MLSS's latest filing, from $1.1 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $13.3 million in Q1 2022 and troughed at $250000.0 in Q1 2026.
• A 5-year average of $4.6 million and a median of $3.3 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2026: Cash & Equivalents soared 120.01% in 2024, then plunged 88.87% in 2026.
• Over 5 years, Cash & Equivalents stood at $8.7 million in 2022, then sank by 65.83% to $3.0 million in 2023, then rose by 9.41% to $3.3 million in 2024, then slumped by 65.85% to $1.1 million in 2025, then sank by 77.53% to $250000.0 in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $250000.0, $1.1 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.